The material has become investigated during the patent literature for its anxiolytic Attributes and diminished sedative, hypnotic, and ataxic aspect-effects, but it does not look like licensed for medical use. ?ukasik-G?ebocka et alPyrazolam is a triazolo-BZD with evidently little data, structurally similar to alprazolam but is brominated in lieu o